Skip to main content
. 2016 Jul 8;11(7):e0158639. doi: 10.1371/journal.pone.0158639

Fig 2. Histological validation of 578T human GBM cell-derived tumors.

Fig 2

To validate tumor formation after subcutaneous (A) and intracranial (B) injections, tissue sections were stained with hematoxylin and eosin (H&E) or immunostained against Ki-67, a cell proliferation marker.